Results 151 to 160 of about 50,906 (248)

Herpes Zoster and Frailty in Older Adults: a Systematic Review. [PDF]

Can Geriatr J
D'Elia MPB, Andrew MK, Pott H.
europepmc   +1 more source

Gene burden meta‐analysis of 748 879 individuals identifies LGI1‐ADAM23 protein complex association with epilepsy

Epilepsia, Volume 67, Issue 7, Page e118-e125, July 2026.
Abstract Epilepsy affects more than 50 million individuals globally and has a substantial genetic component that remains to be completely understood. Traditional studies have focused on severe, early onset cases enrolled through clinical or research settings.
Jessica Castrillon Lal, Costin Leu, Christian M. Boßelmann, Alina Ivaniuk, Eduardo Pérez‐Palma, Dennis Lal   +5 more
wiley   +1 more source

Association of Chronic Diseases With Herpes Zoster in China: A Nationwide Population-Based Survey. [PDF]

Health Care Sci
Zhu W, Xia Y, Wang Y, Shi Z, Shen Y, Cui C, Ai J, Yuan Y, Ye X, Zhu D, He P.   +10 more
europepmc   +1 more source

Mandibular Herpes Zoster

Internal Medicine, 2019
Kosami, Koki, Kenzaka, Tsuneaki
openaire   +3 more sources

Long‐Term Real‐World Evaluation of Tofacitinib's Effectiveness and Safety in Japan: Insights Into Optimal Timing for Dose Reduction

JGH Open, Volume 10, Issue 7, July 2026.
ABSTRACT Aims Tofacitinib (TOF), an oral pan‐Janus kinase (JAK) inhibitor, is a therapeutic option for moderate to severe ulcerative colitis (UC). While short‐term efficacy has been reported, its long‐term real‐world outcomes—particularly in Asian populations—and optimal dose reduction timing are incompletely understood. Methods and Results This single‐
Yoriaki Komeda, Masashi Kono, Tomoyuki Nagai, Shunsuke Omoto, Mamoru Takenaka, Satoru Hagiwara, Naoko Tsuji, George Tribonias, Masatoshi Kudo   +8 more
wiley   +1 more source

Sacral Herpes Zoster Mimicking Pressure Ulcers and Causing Elsberg Syndrome. [PDF]

Clin Case Rep
Yamada J, Yoshida A, Kobayashi T, Kawamura S, Doi S, Eguchi T.   +5 more
europepmc   +1 more source

Real‐World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study)

The Journal of Dermatology, Volume 53, Issue 7, Page 980-989, July 2026.
ABSTRACT Upadacitinib (UPA) is a selective Janus kinase 1 inhibitor that improves moderate‐to‐severe atopic dermatitis, but real‐world strategies to maintain remission after response remain unclear. We conducted a multicenter retrospective study in Japan of 219 patients aged ≥ 12 years who achieved protocol‐defined remission, defined as Investigator's ...
Yuichiro Tsunemi, Atsuyuki Igarashi, Takeshi Ishido, Hidehisa Saeki   +3 more
wiley   +1 more source

2024 Update of the Asia‐Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management

International Journal of Rheumatic Diseases, Volume 29, Issue 7, July 2026.
ABSTRACT Aim To update the Asia‐Pacific League of Associations for Rheumatology (APLAR) treatment recommendations for rheumatoid arthritis (RA) by incorporating new evidence and reassessing the validity of previous guidance: Methods A literature search for relevant publications from January 2018 to August 2023 was conducted, supplemented by earlier ...
Kunihiro Yamaoka, Zhanguo Li, Khin Thin Zar Myo Aung, Paul Bird, Manisha Bhochhibhoya, Minhaj Rahim Choudhury, Debashish Danda, Tsolmon Darisuren, Rudy Hidayat, Nguyen Van Hung, Yuko Kaneko, Wanruchada Katchamart, Manjari Lahiri, Chin Teck Ng, Babur Salim, Keshav Raj Sigdel, Shereen Ch'ng Suyin, Tsutomu Takeuchi, Galymzhan Togizbayev, Evan Vista, Sandini Wijeweera, Chuanhui Xu, Chak Sing Lau   +22 more
wiley   +1 more source

Incidence and factors associated with Herpes Zoster infection in kidney transplant recipients, a recent epidemiological study. [PDF]

Transpl Int
Taton B, Pfirmann P, Garrigue I, Moreau K, Novion M, Jambon F, Merville P, Couzi L, Kaminski H.   +8 more
europepmc   +1 more source

Case Report: Rare Peripheral Neuropathy With Abdominal Wall Allodynia in Extensive‐Stage Small‐Cell Lung Cancer Treated Using Durvalumab

Thoracic Cancer, Volume 17, Issue 14, July 2026.
This case describes a rare allodynia irAE induced by durvalumab in a patient with ES‐SCLC. It is a case of peripheral neuropathy, but the main manifestation differs from most previous cases. First, based on CT, ECG, and cardiac biomarker results, we ruled out cancer‐related pain and organic lesions.
Ruidan Li, Zhen Li, Xiaoqian Zhai, Jie Shao, Yaqin Wang, Qinghua Zhou, Jiewei Liu   +6 more
wiley   +1 more source